// App-Quantinova.ai

1418 : Early T-Cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) Is a High-Risk Subtype in Adults

Researchers

Presenter

  • Nitin Jain

Principal Investigators

  • Audrey Lamb

  • Susan -Brien

  • Michael Rytting

  • Gautam Borthakur

  • Tapan Kadia

  • Farhad Ravandi

  • Marina Konopleva

  • Elias Jabbour

  • Zhuang Zuo

  • Jeffrey L. Jorgensen

  • Pei Lin

  • Sherry Pierce

  • Deborah A Thomas

Medical Centers

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • University of California Irvine Health Chao Family Comprehensive Cancer Center, Orange, CA

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, HOUSTON, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Cluster of Differentiation 1a

  • Cluster of Differentiation 5

  • Cluster of differentiation 8A

Drug/Treatment

  • Nelarabine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved